- Recent Funding
- Investors
- M Ventures
M Ventures portfolio
M Ventures has 21 portfolio companies on record at Recent Funding, with 7 investments in the last 12 months.
About this page
It is a corporate venture investor based in Amsterdam, NL, founded in 2009. It led 13 of the 31 rounds it joined. Its most recent investment on record is T-Therapeutics's $133M Series B+ round in November 2026, alongside Digitalis Ventures, Cambridge Innovation Capital, Johnson & Johnson Innovation and 6 others. By category, its portfolio leans toward Health and bio (15) and AI infrastructure and compute (3). It has co-invested with Pfizer Venture Investments, Cambridge Innovation Capital and EQT Life Sciences, most often Pfizer Venture Investments (6 rounds).
About M Ventures
What M Ventures invests in
- Health and bio · 15 · 71%
- AI infrastructure and compute · 3 · 14%
- Robotics and hardware · 3 · 14%
- Developer tools and cloud · 2 · 10%
- Data and analytics · 1 · 5%
- Commerce and retail · 1 · 5%
- Education · 1 · 5%
- Manufacturing and industrial · 1 · 5%
M Ventures recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $133M | Digitalis Ventures, Cambridge Innovation Capital, Johnson & Johnson Innovation +6 | ||
| Series B+ · $135.04M · lead | EQT Life Sciences, Neva SGR, XGEN Venture +6 | ||
| Series A · $65M | Wellington Management, Oregon Venture Fund, Geodesic Capital +4 | ||
| Seed · $14M | Eli Lilly, Cambridge Innovation Capital, Johnson & Johnson Innovation (lead) +5 | ||
| Series A · $4.1M · lead | Gaingels, Whitecap Venture Partners (lead), Jolt VC +1 | ||
| Series B+ · $56M | Taiho Ventures, UTokyo Innovation Platform, Pfizer Venture Investments +2 | ||
| Series A · $50M | EQT Life Sciences, Novartis Venture Fund, Pfizer Venture Investments | ||
| Series A · $75.5M · lead | 4BIO Capital (lead), Bioqube Ventures, Surveyor Capital +5 |
How M Ventures invests
M Ventures portfolio companies
TT-Therapeutics$133MSeries B+ · Nov 2026
NNouscom$135.04MSeries B+ · Oct 2026
MMueon$65MSeries A · Oct 2026
TTRIMTECH Therapeutics$14MSeed · Jun 2026
FFuture Fertility$4.1MSeries A · Apr 2026
SStorm Therapeutics$56MSeries B+ · Apr 2026
FFoRx Therapeutics$50MSeries A · Dec 2025
AActithera$75.5MSeries A · Jul 2025
BBiolinq$100MSeries B+ · Apr 2025
AAbselion$8.86MSeries A · Dec 2024
KKivu Bioscience$92MSeries A · Oct 2024
FFormo$61MSeries B+ · Oct 2024
IiOnctura$85.8MSeries B+ · Jun 2024
LLabGenius$44MSeries B+ · May 2024
MMetalenz$30MSeries B+ · Oct 2022
WWiliot$200MSeries B+ · Jul 2021
NNeurable$6MSeries A · Dec 2019
TTerragritbacker
NNRG Therapeuticsbacker
LLightcastbacker
EEnara Biobacker
| Company | Round with M Ventures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $133M | $283M | Nov 5, 2026 Series B+ |
Health and bio |
Series B+ · $135.04M · lead | $267.56M | Oct 19, 2026 Series B+ |
AI infrastructure and compute |
Series A · $65M | $80.5M | Oct 15, 2026 Series A |
Health and bio |
Seed · $14M | $45M | Jun 23, 2026 Seed |
Health and bio |
Series A · $4.1M · lead | $4.1M | Apr 23, 2026 Series A |
Health and bio |
Series B+ · $56M | $102.06M | Apr 16, 2026 Series B+ |
Health and bio |
Series A · $50M | $60.87M | Dec 18, 2025 Series A |
Health and bio |
Series A · $75.5M · lead | $75.5M | Jul 9, 2025 Series A |
Health and bio |
Series B+ · $100M | $214.75M | Apr 22, 2025 Series B+ |
Health and bio |
Series A · $8.86M · lead | $8.86M | Dec 4, 2024 Series A |
Health and bio |
Series A · $92M | $92M | Oct 28, 2024 Series A |
Commerce and retail |
Series B+ · $61M | $111M | Oct 9, 2024 Series B+ |
Health and bio |
Series B+ · $85.8M | $108.24M | Jun 20, 2024 Series B+ |
Health and bio |
Series B+ · $44M · lead | $73M | May 21, 2024 Series B+ |
AI infrastructure and compute |
Series B+ · $30M | $70M | Mar 25, 2026 Series B+ |
AI infrastructure and compute |
Series B+ · $200M | $344M | Apr 27, 2026 round |
Robotics and hardware |
Series A · $6M · lead | $43M | Dec 19, 2025 Series A |
| backer | undisclosed | Sep 17, 2026 Seed | |
Health and bio |
backer | $85M | Sep 8, 2025 Series B+ |
Health and bio |
backer | $27M | Apr 14, 2026 round |
Health and bio |
backer | $32.5M | Jun 2, 2026 Series B+ |
Most frequent co-investors
PPfizer Venture Investments6 shared rounds · last Jun 23, 2026
CCambridge Innovation Capital4 shared rounds · last Nov 5, 2026
EEQT Life Sciences4 shared rounds · last Oct 19, 2026
HHikma Ventures4 shared rounds · last Apr 22, 2025
IIntel Capital3 shared rounds · last Oct 15, 2026
LLifeSci Venture Partners3 shared rounds · last Apr 22, 2025
VVI Partners3 shared rounds · last Jun 20, 2024
IInkef3 shared rounds · last Jun 20, 2024
QQualcomm Ventures3 shared rounds · last Jul 27, 2021
SSofinnova Partners2 shared rounds · last Nov 5, 2026
JJohnson & Johnson Innovation2 shared rounds · last Nov 5, 2026
PPanakes Partners2 shared rounds · last Oct 19, 2026
Similar investors
NNovartis Venture Fund21 companies · 3 deals in 12 mo
SSanofi Ventures22 companies · 7 deals in 12 mo
OOptum Ventures16 companies · 4 deals in 12 mo
AAngelini Ventures14 companies · 4 deals in 12 mo
MMitsubishi UFJ Capital37 companies · 10 deals in 12 mo
RRegeneron Ventures10 companies · 5 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 31 rounds on Recent Funding that name M Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists M Ventures, which is a subset of its real portfolio. API: /api/v1/investors/m-ventures (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy